Page 36 - CPG endometrial cancer

แนวทางการตรวจคดั กรอง วินิจฉยั และรกั ษาโรคมะเรง็ เยือ่ บโุ พรงมดลูก 3331

5. Bertelsen K, ?rtoft G, Hansen ES. Survival of Danish Patients With Endometrial Cancer in the Intermediate-Risk
Group Not Given Postoperative Radiotherapy: The Danish Endometrial Cancer Study (DEMCA). International Journal
of Gynecologic Cancer 2011;21:1191-1199.

6. Sorbe B, Nordstr?M B, M?Enp?? J, et al. Intravaginal Brachytherapy in FIGO Stage I Low-Risk Endometrial Cancer: A
Controlled Randomized Study. International Journal of Gynecologic Cancer 2009;19:873-878.

7. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and post-operative radiotherapy versus surgery alone for
patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study
Group. Post Operative Radiation Therapy in Endometrial Carcinoma.Lancet. 2000;355(9213):1404-1411.

8. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic
radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol
Oncol. 2004;92(3):744-751.

9. Group AES, Blake P, Swart AM, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer
(MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, Systematic review, and meta-analysis.
Lancet. 2009;373(9658):137-146.

10. Aalders J, Abeler V, Kolstad P, et al. Postoperative external irradiation and prognostic parameters in stage I
endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980;56:419–27.

11. Sorbe BG, Horvath G, Andersson H, et al. External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as
Postoperative Therapy in Medium-Risk Endometrial Carcinoma: A Prospective, Randomized Study-Quality-of-Life
Analysis. International Journal of Gynecologic Cancer 2012;22:1281-1288.

12. ASTEC Study Group. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy
in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373(9658):125–136.

13. Stelloo E, Nout RA, Osse EM, et al. Improved risk assessment by integrating molecular and clinicopathological factors in
early-stage endometrial cancer-combined analysis of the PORTEC cohorts. Clin Cancer Res. 2016;22(16):4215-4224.

14. Creutzberg CL, Lu KH, Fleming GF. Uterine cancer: adjuvant therapy and management of metastatic disease. J Clin
Oncol. 2019;37(27):2490-2500.

15. Church DN, Stelloo E, Nout RA, et al. Prognostic significance of POLE proofreading mutations in endometrial cancer. J
Natl Cancer Inst 2015;107.

16. Bosse T, Nout RA, McAlpine JN, et al. Molecular classification of grade 3 endometrioid endometrial cancers
identifies distinct prognostic subgroups. Am J Surg Pathol. 2018;42(5):561-568.

17. Le?n-Castillo A, de Boer SM, Powell ME, et al. Molecular classification of the PORTEC-3 trial for high-risk
endometrial cancer: impact on prognosis and benefit from adjuvant therapy. J Clin Oncol 2020;38:3388–97.

18. Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with
endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet.
2010;375(9717):816-823.

19. Creutzberg CL, van Putten WL, Koper PC, et al. Survival after relapse in patients with endometrial cancer: results
from a randomized trial. Gynecol Oncol. 2003;89(2):201-209.

20. Barney BM, Petersen IA, Mariani A, et al. The role of vaginal brachytherapy in the treatment of surgical stage I
papillary serous or clear cell endometrial cancer. Int J Radiat Oncol Biol Phys 2013;85:109–15.

21. Randall ME, Filiaci V, McMeekin DS, et al. Phase III trial: adjuvant pelvic radiation therapy versus vaginal
brachytherapy plus paclitaxel/carboplatin in high-intermediate and high-risk early-stage endometrial cancer. JCO
2019;37:1810–8.

22. Hogberg T, Signorelli M, de Oliveira CF, et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial
cancer–Results from two randomised studies. Eur J Cancer 2010;46:2422–31.